NCT02517580View on ClinicalTrials.gov

Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial)

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Arterial StiffnessVitamin K2 Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin K2 (MK7)

Trial Locations (1)

Unknown

Lebanese American University Medical Center - Rizk Hospital, El Achrafiyé

Sponsors

Collaborators (1)

Omicron Pharmaceuticals

All Listed Sponsors

collaborator

Omicron Pharmaceuticals

INDUSTRY

lead

Lebanese American University

OTHER